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Abstract
Curcumin, a phenolic compound from the curry spice turmeric, exhibits a wide range of activities in eukaryotic cells, including antiviral effects
that are at present incompletely characterized. Curcumin is known to inhibit the histone acetyltransferase activity of the transcriptional coactivator
proteins p300 and CBP, which are recruited to the immediate early (IE) gene promoters of herpes simplex virus type 1 (HSV-1) by the viral
transactivator protein VP16. We tested the hypothesis that curcumin, by inhibiting these coactivators, would block viral infection and gene
expression. In cell culture assays, curcumin significantly decreased HSV-1 infectivity and IE gene expression. Entry of viral DNA to the host cell
nucleus and binding of VP16 to IE gene promoters was not affected by curcumin, but recruitment of RNA polymerase II to those promoters was
significantly diminished. However, these effects were observed using lower curcumin concentrations than those required to substantially inhibit
global H3 acetylation. No changes were observed in histone H3 occupancy or acetylation at viral IE gene promoters. Furthermore, p300 and CBP
recruitment to IE gene promoters was not affected by the presence of curcumin. Finally, disruption of p300 expression using a short hairpin RNA
did not affect viral IE gene expression. These results suggest that curcumin affects VP16-mediated recruitment of RNA polymerase II to IE gene
promoters by a mechanism independent of p300/CBP histone acetyltransferase activity.
© 2007 Elsevier Inc. All rights reserved.Keywords: Curcumin; Chromatin; Coactivator; Transcriptional activation; Lytic infection; VP16Introduction
Curcumin (diferuloylmethane) is the major component of the
curry spice turmeric (Curcuma longa Linn.). Curcumin can affect
the metabolism of cells and organisms in a number of ways,
including apoptosis, cell signaling, inflammation, and carcino-
genesis (reviewed in Joe et al., 2004; Sharma et al., 2005). Various
antiviral effects of curcumin have been described, but the bio-
chemical mechanisms of those effects have been incompletely
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doi:10.1016/j.virol.2007.11.028Mazumder et al., 1995; Sui et al., 1993). Curcumin reportedly
inhibits transcription and replication of the human immunodefi-
ciency virus (HIV-1) by blocking Tat-mediated transactivation or
by diminishing viral protease and integrase activity (Burke et al.,
1995; Li et al., 1993; Mazumder et al., 1995; Sui et al., 1993).
Virions of herpes simplex virus type 2 (HSV-2)were rendered less
infectious by exposure to curcumin prior to infection of HeLa
cells or of mouse genitalia (Bourne et al., 1999). In some cases,
the antiviral effects of curcumin arise from inhibition of a cellular
process or a transcription factor. For example, curcumin has been
shown to suppress transcription activation by the host protein AP-
1 (Balasubramanian and Eckert, 2006) leading to diminished
HTLV-1 and HPV-mediated cellular transformation (Divya and
Pillai, 2006; Prusty and Das, 2005; Tomita et al., 2006).
The packaging of eukaryotic DNA in the form of chromatin
presents a significant impediment to the transcriptional machinery
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coactivator proteins that typically comprise multi-protein com-
plexes with either of two types of enzymatic activities. Some
coactivators covalently modify histones by acetylation, methyla-
tion, phosphorylation, ubiquitinylation, prolyl isomerization, or
ADP-ribosylation (Iizuka and Smith, 2003; Jenuwein and Allis,
2001; Lo et al., 2004; Mellor, 2006; Nelson et al., 2006; Turner,
2000). Other coactivators hydrolyze ATP in the process of remo-
deling the position of nucleosomes along DNA or in removing
nucleosomes from DNA (Johnson et al., 2005; Smith and
Peterson, 2005). Curcumin inhibits the histone acetyltransferase
(HAT) activity of the closely related transcriptional coactivator
proteins p300 and CBP in vitro (IC50 of 25 μM) and in vivo
(Balasubramanyam et al., 2004; Marcu et al., 2006). This inhi-
bition might disrupt expression of genes dependent on those
coactivators.
Herpes simplex virus type 1 (HSV-1) is a large DNA virus
with a linear double stranded genome of 152 kb. Upon entry by
fusion of its envelope with the host cell plasma membrane, the
viral capsid is transported to the nuclear pore and the viral
genome is released into the nucleus which starts the temporally
regulated gene expression cascade involving transcription of
immediate-early (IE or α), early (E or β), and late (L or γ)
genes. IE gene transcription is strongly stimulated by the virion-
borne transactivator VP16 (Campbell et al., 1984; Walker et al.,
1993). VP16 comprises a core domain (residues 1–410) and an
acidic activation domain (AD) (residues 413–490), which has
often been used for creating novel transactivators in hetero-
logous expression systems (Sadowski et al., 1988; Triezenberg,
1995). VP16 is recruited to TAATGARAT motifs on IE gene
promoters through interactions of its core domain with two host
proteins, HCF and Oct-1, forming the VP16-induced complex
(VIC) (Wysocka and Herr, 2003). VP16, mainly by its
activation domain, then interacts with various general transcrip-
tion factors and recruits RNA polymerase II (RNAP II) ma-
chinery (Goodrich et al., 1993; Ingles et al., 1991; Klemm et al.,
1995; Lin et al., 1991; Uesugi et al., 1997; Xiao et al., 1994).
Although the HSV-1 genome has long been suggested to be
nonnucleosomal during lytic infection (Leinbach and Summers,
1980; Lentine and Bachenheimer, 1990; Muggeridge and Fra-
ser, 1986; Muller et al., 1980), we and others have recently
reported that histone H3 is associated with the HSV-1 genome
and that histone tail modifications such as methylation and
acetylation can be detected on transcriptionally active viral
promoters and ORFs (Herrera and Triezenberg, 2004; Huang
et al., 2006; Kent et al., 2004). We have also shown that p300
and CBP HATs are recruited to IE gene promoters in a manner
dependent on the VP16 AD (Herrera and Triezenberg, 2004),
suggesting that histone acetylation by p300/CBP on the viral
genome might be important for IE gene expression.
Since curcumin inhibits p300/CBP HATactivity, we wanted
to test whether curcumin could act as a potential anti-herpetic
compound by inhibiting IE gene expression. In this report, we
show that curcumin treatment of HeLa cells at nontoxic levels
slows HSV-1 replication and decreases the ability of cells to
support infection by HSV-1. This effect is mediated at least in
part by inhibition of IE gene expression, since curcumin re-duced the recruitment of RNAP II to IE gene promoters but not
to cellular control promoters. However, the concentrations of
curcumin required for these effects on viral gene expression
were far less than the concentrations required to substantially
inhibit global H3 acetylation. Moreover, the occupancy of
histone H3 on IE gene promoters and the acetylation of H3 at
those promoters did not change significantly in the presence
of curcumin. Furthermore, no effect on viral gene expression
was observed when p300 expression was disrupted by a short
hairpin RNA. These results suggest that curcumin might inhibit
recruitment of RNAP II machinery through a mechanism in-
dependent of the effect of curcumin on p300 or CBP HAT
activity.
Results
Curcumin diminishes HSV-1 infectivity and slows HSV-1
replication
A previous report indicated that curcumin could reduce the
infectivity of HSV-2 virions when the chemical was added to
virus preparations prior to infection (Bourne et al., 1999). This
observation suggests that curcumin has a biochemical effect on
the structure or integrity of the virion itself. Given the evidence
that curcumin can also inhibit a range of cellular processes on
which viral gene expression and replication might depend, we
tested whether the ability of cells to support HSV-1 infection and
replication was altered by the presence of curcumin. To address
whether curcumin inhibits infection by HSV-1, we performed
plaque assays in cells that were treated with curcumin. The
presence of curcumin reduced the number of plaques on Vero
cell monolayers by approximately threefold (Fig. 1A). The
plaque size, which reflects multiple rounds of infection, was also
affected by curcumin. After 3 days, the mean plaque size in the
presence of curcumin was 0.62 (+0.10) mm, whereas the mean
plaque size in untreated cells was 0.73 (+0.13) mm. The plaque
size distributions in treated and untreated cells (Fig. 1B) are
significantly different ( pb0.00005 byWilcoxon rank-sum test).
The plaque morphology was also different in treated and
untreated cells (Fig. 1C). In curcumin-treated cells, although the
cytopathic effects of late-stage HSV-1 infection were obvious in
the middle of the plaque, the plaque was not cleared as in
untreated cells. This effect might also be an indication that the
lytic infectious cycle is slowed in the presence of curcumin.
These results suggest that curcumin reduces the ability of cells to
support HSV-1 infection, and that curcumin slows but does not
totally block HSV-1 replication.
We then tested further the effect of curcumin on viral re-
plication kinetics and production of infectious virions. Fig. 1D
shows the results of a single-step growth curve assay indicating
that production of infectious virus was diminished in cells
treated with curcumin. In mock-treated Vero cells, production of
infectious progeny virus reached a maximum of approximately
108 plaque-forming units per ml (pfu/ml) by 12 h post-infection
(hpi). In the presence of curcumin, progeny virus titers were
lower throughout the infection period, but did increase steadily
to a maximum of approximately 107 pfu/ml. We conclude that
Fig. 2. Effects of curcumin on HSV-1 IE gene expression. (A) HeLa cells were
pretreated with 20 μM curcumin (+, black bars) or DMSO only (−, open bars)
for 3 h and then infected with HSV-1 at an MOI of 1 pfu/cell. Total RNAwas
isolated at 2 hpi and gene expression was analyzed by Q-RT-PCR, normalized
against 18S rRNA levels. Mean values from three experiments for each gene
tested are shown relative to values obtained from untreated cells; error bars
represent standard deviations. (B) HeLa cells were infected with HSV-1 in
the presence (+, black bars) or absence (−, open bars) of 20 μM curcumin.
Aliquots of nuclear extracts (as used in ChIP assays, Fig. 3) were analyzed by
Q-PCR. The amount of viral DNA (represented by the ICP27 gene promoter)
was normalized against cellular DNA (represented by the U3 snRNA pro-
moter). Error bars represent the standard deviation among five independent
experiments.
Fig. 1. Effects of curcumin on HSV-1 plaque formation and viral replication.
(A) Plaque assays were performed in Vero cells pretreated (+) with 10 μM
curcumin or untreated (−) for 2 h and infected with serial dilutions of a stock
preparation of HSV-1. 10 μM curcumin was also present in the viral inocula and
overlay agar media of treated samples. Error bars represent the standard deviation
among triplicate assays at two viral dilutions. (B) Plaque sizes in the absence (open
circles) or presence (closed circles) of curcumin were measured by averaging
randomly chosen vertical and horizontal diameters of plaques. The numbers of
plaques within various size ranges (from less than 0.5 mm to greater than 0.9 mm)
are shown. (C) Representative plaques from plaque assays performed in the
absence (left panel) and presence (right panel) of 10 μM curcumin. Scale bar:
100 μm. (D) Single-step growth curves were performed in Vero cells infected with
HSV-1 at an MOI of 1 pfu/cell. Virus titers in samples collected at 4 h intervals
were assayed in triplicate on Vero cells. Closed circles represent curcumin-treated
samples; open circles represent parallel cultures of untreated cells.
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support HSV-1 infection and slows but does not block the viral
replication cycle.Curcumin inhibits IE gene expression without affecting the
delivery of the viral genome to the nucleus
We have previously reported that the transcriptional coacti-
vator and histone acetyltransferase proteins p300 and CBP are
recruited to IE gene promoters in a manner dependent on the
VP16 transcriptional activation domain (Herrera and Triezen-
berg, 2004). Curcumin can inhibit the HAT activity of p300 and
CBP but not of other mammalian coactivators such as PCAF
(Balasubramanyam et al., 2004). We hypothesized that if the
HAT activities of p300 and CBP are important for IE gene
expression and if curcumin inhibits that activity, then curcumin
would inhibit IE gene expression. Indeed, in HeLa cells treated
with nontoxic levels of curcumin and infected at a multiplicity of
1 pfu/cell, the steady-state mRNA levels for the IE genes ICP4
and ICP27 were significantly reduced (Fig. 2A), whereas levels
of CBP transcripts (Fig. 2A) and p300 transcripts (data not
shown) were unchanged. This result suggests that curcumin
inhibits VP16-dependent transcription activation, potentially by
inhibiting p300/CBP HATactivity. Since curcumin accumulates
in various cellular membranes (Jaruga et al., 1998), we were
concerned that it might interfere with viral entry or delivery of
the viral genome to the nucleus, which would result in di-
minished IE gene expression. This concern was alleviated by
assaying viral DNA levels in the nuclear fractions of curcumin-
treated and mock-treated cells. Quantitative PCR results shown
in Fig. 2B show no difference in viral DNA levels between
treated and untreated cells. We conclude that curcumin treatment
does not disrupt the delivery of viral genomes to the infected cell
nucleus, and infer that curcumin has a more direct role in
inhibiting IE gene transcription.
Fig. 4. Curcumin does not affect histone H3, p300, or CBP occupancy, nor H3
acetylation, at IE genes. (A) HeLa cells were treated with curcumin (concen-
trations given in μM) for various times in the presence of 1.4 μM trichostatin A.
Acid extracted histones were analyzed by immunoblotting using antibodies
directed against H3 acetylated at Lys9 and Lys14 (top panel) or a carboxyl-
terminal epitope of H3 (bottom panel). (B–F) Chromatin immunoprecipitation
was performed as described for Fig. 3, but using antibodies against the H3
carboxyl-terminal domain (B), H3 acetylated at Lys9 (C), H3 acetylated at
Lys14 (D), the coactivator p300 (E), or the coactivator CBP (F). The % input
values in B–D were further normalized to U3 snRNA promoter as a means to
control immunoprecipitation efficiency. Since the p300/CBP IP efficiencies
were low, these data are represented as fold enrichment over no antibody control.
Error bars represent the standard deviation among six (for ICP27 promoter) and
four (for c-fos promoter) independent experiments (D, E). p-values in D and E
were determined by Student's t-test.
Fig. 3. Curcumin decreases occupancy of RNA polymerase II but not of VP16 at
IE genes. HeLa cells treated with 20 μM curcumin (+, black bars) or DMSO
only (−, open bars) were infected with HSV-1 at an MOI of 5 pfu/cell. Chro-
matin immunoprecipitation from sonicated nuclear extracts was performed
using antibodies against VP16 (A) or RNA pol II (B). Samples were analyzed by
Q-PCR using primers specific for the ICP0 promoter, ICP27 promoter, ICP27
ORF, or the cellular U3 snRNA promoter. Aliquots of samples prior to immu-
noprecipitation (1%, 0.3%, 0.1%, 0.04% input) were used to create a standard
curve of input DNA. This curve was used to determine the relative amounts of a
given DNA fragment in immunoprecipitated or control (no antibody) samples.
The values for no-antibody controls were subtracted from the values for cor-
responding IP samples. Error bars represent the range between technical du-
plicates for a representative experiment.
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and ORFs but does not affect recruitment of VP16
One way that curcumin might block IE gene expression is by
decreasing the recruitment of VP16 to IE gene promoters.
Alternatively, curcumin might affect recruitment of RNAP II
without affecting VP16 occupancy. To test these hypotheses, we
performed chromatin immunoprecipitation (ChIP) assays to
probe the presence of VP16 and RNAP II at IE genes in HeLa
cells infected at an MOI of 5 pfu/cell. Curcumin had no sub-
stantial effect on the recruitment of VP16 to the ICP0 or ICP27
promoters (Fig. 3A). The U3 snRNA gene promoter served as a
negative control, showing that VP16 occupancy as detected by
ChIP assays was specific to viral IE promoters, as previously
shown (Herrera and Triezenberg, 2004). In contrast, curcumin
caused a significant decrease in the occupancy of RNAP II
on both the promoter and transcribed region (ORF) of ICP27
(Fig. 3B). Similar decreases in RNAP II occupancy were ob-
served for the ICP0 gene promoter (data not shown). The mo-
dest effect of curcumin on the presence of RNAP II on the U3
snRNA promoter was not observed in other replicates of this
experiment (data not shown). We conclude that curcumin de-
creases VP16-dependent recruitment of RNAP II and hence IE
gene expression.
Curcumin has no significant effect on H3, AcH3, p300, and
CBP occupancy on IE gene promoters and ORFs
One of the potential ways that curcumin might inhibit RNAP
II recruitment is by inhibiting p300/CBP HAT activity (Bala-
subramanyam et al., 2004; Marcu et al., 2006), thus permitting
formation of transcriptionally repressive chromatin on viral
DNA. We first tested whether the levels of curcumin (20 μM)
that inhibit viral gene expression also affect total acetylation
levels of histone H3. An immunoblot using an antibody specificto acetylated Lys9 and Lys14 of H3 revealed no significant
change in total histone H3 acetylation after 3 h, 5 h, or overnight
incubation in 20 μM curcumin (Fig. 4A). The 3 h and 5 h times
correspond to beginning and end of viral infection, respectively,
for the viral gene expression analysis indicated in Fig. 2A. A
decrease in histone H3 acetylation was observed only after
overnight incubation in the presence of higher curcumin con-
centrations (Fig. 4A). We infer that, under the conditions used in
viral gene expression assays, curcumin does not significantly
inhibit p300/CBP HAT activity.
We have previously shown that HSV-1 IE gene promoters
are relatively devoid of histone H3 at 2 hpi, but that H3 and
acetylated H3 can be found at IE gene ORFs and also at DE and
L gene promoters at that time (Herrera and Triezenberg, 2004).
However, during infection with a mutant virus (strain RP5)
lacking the VP16 activation domain, H3 did associate with IE
Fig. 5. Knocking down p300 expression does not affect HSV-1 IE gene ex-
pression. HeLa cells were transfected with 3 μg of pSUPER (empty) or pSUPER-
p300 plasmid that expresses a shRNA targeting p300. Forty-eight hours post-
transfection, cells were infected with HSV-1 at an MOI of 5 pfu/cell and total
protein and RNAwere isolated. p300 knockdown efficiency was analyzed by
immunoblotting (A) and Q-RT-PCR (B). IE gene expression was analyzed by
Q-RT-PCR as indicated in previous figure legends (C). Data represent the
average of three independent experiments done at least in biological duplicates.
Error bars represent the standard deviation.
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promoters were reduced. On that basis, we hypothesized that
p300/CBP HAT activity might be required for covalent modi-
fication and subsequent removal of histones from IE gene
promoters, to allow recognition of those promoters by RNAP II.
That model led to the prediction that curcumin, by inhibiting
p300/CBP HAT activity, would diminish levels of acetylated
histones at IE gene promoters and ORFs, and would increase the
level of H3 at IE gene promoters, as observed during RP5
infection (Herrera and Triezenberg, 2004).
ChIP assays were performed using antibodies that recognize
an H3 carboxyl-terminal epitope unaffected by known mod-
ifications or antibodies specific to H3 acetylated at either Lys9 or
Lys14. Contrary to our hypothesis, we observed no significant
increase in H3 occupancy (Fig. 4B) and no significant decrease
in K9-acetylated H3 (Fig. 4C) or K14-acetylated H3 (Fig. 4D)
occupancy on the ICP27 promoter or ORF. We conclude that the
inhibition of IE gene expression caused by curcumin is not the
result of changes in histone occupancy or acetylation at IE gene
promoters, and thus the HAT activity of CBP and p300 is not
likely to be critical for viral IE gene expression.
A recent report has suggested that relatively high concentra-
tions of curcumin can inhibit the recruitment of p300 to pro-
moter DNA fragments in vitro (Black et al., 2006). Thus, we
considered the possibility that although their HATactivity per se
might not be required, p300 and CBP might act as scaffolding
proteins at IE gene promoters for the recruitment of other
transcription factors. We used ChIP assays to test whether cur-
cumin inhibits the recruitment of p300 and CBP to IE genepromoters. The results (Figs. 4E, F) indicate that curcumin did
not block the recruitment of p300 or CBP to IE gene promoters
nor to the c-fos promoter, which was previously shown to be
dependent on p300/CBP (Janknecht and Nordheim, 1996;
Ramirez et al., 1997). Instead, we observed a modest increase in
recruitment of p300 and CBP at the ICP27 promoter. One
potential explanation for this increase is that curcumin can
inhibit the autoacetylation of p300 or CBP and hence inhibit the
dissociation of CBP or p300 from the ICP27 gene promoter,
which would in turn prevent the recruitment of RNAP II. Taken
together, these results suggest that curcumin affects recruitment
of RNAP II to the HSV-1 genome but not to cellular control
gene promoters, and that this effect is independent of the effects
of curcumin on p300 and CBP HAT activity.
Diminished expression of p300 does not affect IE gene
expression
In order to validate the conclusion that curcumin inhibits IE
gene expression independent of p300 HAT activity, we have
analyzed IE gene expression when p300 expression was dimi-
nished byRNA interference. Transfection of a plasmid expressing
a short hairpin RNA (shRNA) specific for p300 resulted in
efficient disruption of p300 expression assessed as either protein
(Fig. 5A) or as mRNA (Fig. 5B). The disruption was specific for
p300, since CBP expression was not affected (Fig. 5B). However,
viral IE gene expression was not significantly affected (Fig. 5C),
suggesting that p300 is not required for HSV-1 IE gene ex-
pression. This result also argues against the possible role of p300
as a scaffolding protein on IE gene promoters. Another possible
explanation is that p300 and CBPmay act redundantly on viral IE
gene promoters and therefore knocking down only p300 does not
affect IE gene expression. We are currently working on a more
detailed analysis of coactivator disruption, which will be the
subject of another manuscript. Our preliminary results suggest
that neither p300 nor CBP are essential for IE gene expression
(Kutluay, et al., manuscript in preparation).
Discussion
This study was performed to assess whether curcumin would
act as an antiviral agent for HSV-1 infection, based on the
hypothesis that curcumin could prevent IE gene expression by
inhibiting the p300 and CBP HATs (Balasubramanyam et al.,
2004) that are recruited to IE gene promoters during lytic in-
fection (Herrera and Triezenberg, 2004). Our results demon-
strate that curcumin-treated cells are indeed diminished in their
ability to support HSV-1 infection and replication. The presence
of curcumin did not block the delivery of the viral genome to the
nucleus, indicating that binding, entry, and intracellular transit of
the virus are not substantially affected by curcumin. We did
observe a significant decrease in expression of viral IE genes,
corresponding to diminished recruitment of RNAP II to IE gene
promoters. These outcomes are all consistent with the hypothesis
that curcumin specifically affects viral IE gene expression.
However, additional observations suggest that the antiviral
effects of curcumin do not arise through the mechanism initially
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evident using concentrations and times much less than those
required for significant inhibition of overall histone acetylation.
We expected that curcumin, as an inhibitor of p300 and CBP
HATactivity, would result in diminished histone acetylation and
increased histone H3 occupancy at IE gene promoters, but those
effects were not observed. Moreover, disruption of p300 protein
expression had no significant effect on IE gene expression. We
conclude that the HAT activity of p300 and CBP is not essential
for histone clearance from HSV IE gene promoters or for IE
gene expression, but that curcumin blocks other, yet unknown
steps that are required for recruitment of RNAP II and sub-
sequent transcription of IE genes. We cannot yet exclude the
possibility that other HATs such as PCAF and hGCN5 may act
redundantly on viral genes, masking any curcumin-dependent
changes in histone acetylation (Chan and La Thangue, 2001).
Several potential mechanisms whereby curcumin blocks IE
gene expression can be eliminated based on additional ChIP
assays. The recruitment of the virion-borne activator protein
VP16 to IE promoters was not affected by curcumin. Although a
prior report suggested that curcumin can inhibit recruitment of
p300 to target gene promoters by the chimeric activator protein
Gal4-VP16 in an in vitro experiment (Black et al., 2006), we
observed no effect of curcumin on p300 or CBP occupancy on
IE gene promoters. One possible reason for this discrepancy
might be the high concentrations of curcumin (300 μM) used in
the in vitro system (Black et al., 2006), whereas we used 10–
20 μM curcumin because of cytotoxicity observed at higher
concentrations and long incubation periods.
Our observation that the occupancy of histone H3 and
acetylated H3 on IE gene promoters and ORFs did not change
upon curcumin treatment leads to the question of why the dra-
matic decrease in viral gene expression does not correspond to
an increase in histone occupancy on the viral genome. Since
histones are not packaged with the HSV-1 genome in virion
particles (Gibson and Roizman, 1971), one possibility is that the
level of histone deposition on the viral genome at 2 h post-
infection is still relatively low compared to cellular genes and
hence the histones do not create a substantial barrier for tran-
scription. Another possibility is that the VP16 activation domain
recruits other coactivators such as the chromatin remodeling
enzymes Brm and Brg-1 (Herrera and Triezenberg, 2004),
independent of the HAT activities of CBP and p300, to keep the
viral genome free of histones. In support of the latter hypothesis,
VP16 AD has been recently shown to recruit the yeast remo-
deling complex SWI/SNF to mono- and dinucleosomal arrays to
catalyze the eviction of nucleosomes by SWI/SNF (Gutierrez
et al., 2007). These hypotheses will be tested in the context of
viral infection in future experiments.
We note that the relatively modest effects of curcumin on the
viral infection and replication (Fig. 1) do not seem to reflect the
dramatic reduction in IE gene expression (Fig. 2A) and in
RNAP II recruitment to IE promoters (Fig. 3B). We suspect that
this discrepancy may be due to the decay of the biological
activity of curcumin when exposed to light or to cell culture
media (Blasius et al., 2004; Wang et al., 1997) in the longer
experiments probing viral infection and replication, relative tothe shorter experiments used for IE gene expression and ChIP
assays.
Others have reported that virions of HSV-2 were rendered
less infectious by exposure to curcumin prior to infection of
HeLa cells or of mouse genitalia (Bourne et al., 1999). To date,
no biochemical mechanism for this virucidal effect has been
established. In contrast, the work presented here indicates that
curcumin can inhibit viral gene expression and thus replication
through mechanisms operative within the infected cells. This is
especially evident in our observations that curcumin did not
affect delivery of viral DNA to the nucleus, but had a dramatic
effect on IE gene expression (Fig. 2). Nonetheless, we cannot
fully exclude the possibility that the virucidal effects of cur-
cumin might contribute to the diminished replication and plaque
formation evident in Fig. 1.
Although curcumin has been widely studied in the context of
cancer and apoptosis, the current literature does not clearly define
the effects of curcumin on RNAP II machinery or transcription
factors. One report has shown that curcumin inhibits certain
cellular differentiation events by triggering protease-dependent
degradation of the transcription factor AP-1 (Balasubramanian
and Eckert, 2006). Although our results cannot directly exclude
the possibility that VP16 is degraded similarly, our ChIP data
suggest that more or less equivalent amounts of VP16 are im-
munoprecipitated with IE gene promoters and hence the mech-
anism whereby curcumin inhibits viral IE gene expression is
unlikely to be mediated by degradation of VP16. The ChIP re-
sults also suggest that curcumin does not prevent the formation of
the DNA-binding protein complex comprising VP16, Oct-1, and
HCF. Since VP16 itself cannot bind to DNA with high affinity
(Babb et al., 2001; Kristie and Sharp, 1990;Marsden et al., 1987)
if curcumin was preventing the interaction between VP16, Oct-1,
and HCF, then less VP16 would have been immunoprecipitated
to IE gene promoters in the presence of curcumin.
Curcumin is a potent compound with various biological prop-
erties. We have shown that curcumin significantly affects HSV-1
IE gene expression which thereby diminishes the ability of the
virus to launch the lytic infectious cycle.Whether curcumin can be
used as an anti-HSV-1 therapeutic agent will likely be limited by its
low bioavailability and high degradation rates when exposed to
light. Moreover it is still not known how curcumin is metabolized
in vivo and how these by-products might affect cellular processes.
Therefore understanding the fate of curcumin in vivo is key to
developing curcumin as an alternative drug for HSV-1 treatment.
Hence, our results can be considered as an early step in elucidating
the molecular basis of the antiviral activities of curcumin.
Methods
Cell lines, viruses, and treatment
HeLa (Cat.# CCL-2) and Vero (Cat.# CCL-81) cells obtained
from the American Type Culture Collection were grown in
Dulbecco's modified Eagle's medium (DMEM, Gibco) supple-
mented with 10% fetal bovine serum (FBS, Gibco). The KOS
strain of HSV-1 was used to infect HeLa cells at a multiplicity of
infection (MOI) of 1–5 pfu/cell, titered in Vero cells. Curcumin
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(DMSO). Trichostatin A (TSA) (Sigma, Cat.# T8552) was
dissolved in ethanol. Cells in normal growth media were treated
with curcumin as indicated in figure legends.
Plasmids and transfection
Construction of the pSUPER-p300 plasmid has been pre-
viously described (Ducat et al., 2003). Briefly, a 64-mer double-
stranded oligonucleotide targeting p300 was cloned into the
pSUPER vector (OligoEngine) digested with BglII and HindIII.
The oligonucleotide sequences are as follows, with bold font
indicating the p300-specific region:
Forward primer: 5′-GAT CCC CGT CTT GGC ATG GTA
CAA GAT TCA AGA GAT CTT GTA CCA TGC CAA
GAC TTT TTG GAA A-3′
Reverse primer: 5′-AGC TTT TCC AAA AAG TCT TGG
CATGGTACAAGATCT CTT GAATCT TGTACCATG
CCA AGA CGG G-3′
HeLa cells were transfected with 3 μg of the indicated plas-
mids using Lipofectamine 2000 (Invitrogen) according to
manufacturer's instructions.
Single-step growth curve
To determine growth curves of HSV-1 in the presence and
absence of curcumin, Vero cells were plated at a density of 1×106
cells per 60 mm tissue culture plate. After 24 h, cells were
pretreated for 2 h with 20 μM curcumin prior to infection at a
multiplicity of 1 pfu/cell. Duplicate samples were harvested at 4-h
intervals by dislodging cells into the overlying medium with a
disposable scraper. The cells were disrupted by sonication and
insoluble cell debris was removed by centrifugation. The titer of
each sample was determined in triplicate by plaque assay.
Plaque assay
Plaque assays were performed by infecting nearly confluent
60 mm plates of Vero cells in triplicate for each virus dilution.
100μl of each dilutionwas added to plates and plates were rocked
every 15 min for 1 h. After 1 h, cells were washed with DMEM
lacking FBS and then overlaid with DMEM containing 2% FBS
and 0.9% Sea Plaque Agarose. After 3 days, plates were stained
with neutral red (0.2 mg/ml in PBS) and incubated onemore hour
for visualization of plaques. Plaque sizes were measured using a
Nikon Eclipse TE300 microscope equipped with a Hamamatsu
digital camera, C4742-95, using OpenLab software.
ChIP assay
Chromatin immunoprecipitation (ChIP) assayswere performed
as described previously (Herrera and Triezenberg, 2004). Briefly,
HeLa cells were fixed with 1% formaldehyde and were collected
in a hypotonic buffer (5 mM PIPES, pH 8.0, 85 mM KCl, 0.5%
IGEPAL CA-630 with protease inhibitors). Nuclei were releasedby dounce homogenizer, collected, and sonicated to obtain 200 to
500 bp DNA fragments. After preclearing with protein G-agarose
beads, IPs were performed overnight at 4 °C. Antigen–antibody
complexes were precipitated by using protein G-agarose beads.
Beads were washed and the protein DNA complexes were eluted
with 100 μl of 50 mM Tris–HCl (pH 8.0)–10 mM EDTA–1%
sodium dodecyl sulfate for 20 min at 65 °C. Cross-links in DNA–
protein complexes were reversed by overnight incubation at 65 °C
and then precipitated with ethanol. DNAwas then further purified
by Proteinase K digestion, phenol:chloroform (1:1) extraction and
ethanol precipitation. DNA samples were resuspended in 75 μl of
water and subjected to quantitative real-time PCR analysis.
ChIP assays were performed using antibodies or antisera
directed against VP16 (Triezenberg et al., 1988), RNA Pol II
(8WG16, Covance), CBP (A-22, Santa Cruz Biotechnology),
p300 (N-15, Santa Cruz Biotechnology), histone H3 acetylated
at Lys9 (07-352, Upstate), histone H3 acetylated at Lys14 (07-
353, Upstate), and a C-terminal epitope of histone H3 (ab1791,
Abcam). Control IPs were performed using no antibodies.
RNA isolation, reverse transcription, Q-PCR
Total RNA was isolated by Trizol according to manufac-
turer's instructions. One microgram RNA was reverse tran-
scribed using the Reverse Transcription System (Promega).
Quantitative real-time PCR analysis for gene expression and
ChIP experiments was performed by SYBR Green assay using
ABI 7500 real-time PCR system (Applied Biosystems). The
primer pair for the c-fos promoter was 5′-GAACTGCGAA-
ATGCTCACGAGATTA-3′ (forward) and 5′-AGTGTAAA-
CGTCACGGGCTCAA-3′ (reverse). The primer pair for p300
was 5′-CAATGAGATCCAAGGGGAGA-3′ (forward) and 5′-
ATGCATCTTTCTTCCGCACT-3′ (reverse). The primer pair
for CBP was 5′-GTGCTGGCTGAGACCCTAAC-3′ (forward)
and 5′-GGCTGTCCAAATGGACTTGT-3′ (reverse). Other
primer pairs were previously described (Herrera and Triezen-
berg, 2004; Ottosen et al., 2006).
Western blot analysis
Histones from HeLa cells were isolated by acid-extraction.
In brief, nuclei were released by Triton extraction buffer (PBS
containing 0.5% Triton X-100 (v/v) and PMSF) and collected.
Histones were then extracted using 0.2 N hydrochloric acid.
Acid soluble proteins were loaded onto a 15% sodium dodecyl
sulfate-polyacrylamide gel. Proteins were transferred to nitro-
cellulose membrane, blocked at room temperature for 1 h in 5%
BSA/TTBS, and proteins were identified using antibodies
specific to histone H3 (ab1791, Abcam) or H3 acetylated at
Lys9 and Lys14 (06-599, Upstate).
For the p300 western blot, total cell lysate was prepared from
cells byRIPAbuffer and loaded onto a 6% sodiumdodecyl sulfate-
polyacrylamide gel. Proteins were transferred to a nitrocellulose
membrane and blocked at 4 °C overnight in 5% nonfat dry milk-
TTBS. p300 was detected by a rabbit polyclonal antibody from
Santa Cruz (SC-584). GAPDH was detected by a mouse
monoclonal antibody from Chemicon (MAB374).
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